The ability of the incretin agents (glucagon-like peptide 1 [GLP-1] agonists and dipeptidyl peptidase IV [DPP-4] inhibitors) to improve glycaemia with a low associated risk of hypoglycaemia, together with beneficial/neutral effects on body weight, offers a significant advantage for both patients and treating clinicians
This transdermal spray delivers estrogen directly through the skin just like a patch, maintaining steady systemic absorption without relying on backordered patch supplies
(PubMed) Babaknejad N, Sayehmiri F, Sayehmiri K, et al
No direct research examines BPC-157 for keloids specifically
World Health Organization, Geneva Krass I, Schieback P, Dhippayom T (2015) Adherence to diabetes medication: a systematic review
Its single-use pen system appeals to those seeking straightforward administration